Skip to main content

      Delivering affordable weight loss solutions

      How are we reshaping weight management? By using our size to negotiate lower prices from drug manufacturers. By leveraging the competition for a more affordable, optimized formulary. And by offering an integrated program that combines clinical and behavioral benefits for effective results.

      Making GLP-1s more accessible

      A person holds a GLP-1 container in their hand.

      For healthier outcomes

      GLP-1s can be a transformative part of weight management. As demand grows and the market evolves, we’re committed to working with payors to best support their members while balancing costs.

      Read more about GLP-1 management insights

      $500M-600M

      potential savings over 12 months* with this program

      A program that helps members succeed

       

      Now available through CVS Healthspire®, our best-in-class weight management program integrates pharmacy benefits with personalized lifestyle support. So members get exactly what they need to reach their goals.

       

      Learn more about the program from CVS Healthspire

      A person lifts exercise weights in their home.

      Real progress. Real change. Real results.

      What’s new in the pharmacy benefits world?

      Find out what’s new and next so you can stay on top of what you need to keep members healthier and reach your goals.

      Subscribe for content

      Get in touch

      Let us know if you want to learn more about controlling your costs and making medication affordable for your members.

      Contact us

      • *FOR $500M to $600M POTENTIAL SAVINGS OVER 12 MONTHS SOURCE: While we initially estimated about $270M to $390M in client savings, the additional rate improvement we were able to obtain on this strategy suggests that we will save roughly double this amount, $500M to $600M over the 12 months following our change. Pharmacy paid claims for Zepbound, Wegovy and Mounjaro for Commercial Book of business (excludes restricted clients), July 2024 to April 2025. For template formulary only. 

      • *FOR 18.5% AVERAGE WEIGHT LOSS FOR PROGRAM MEMBERS SOURCE: Reflects data from clients who implemented CVS Weight Management® program in 2024, showing average weight loss among engaged members who have been on anti-obesity medication for one year. CVS Health® Analytics, 2025.

      • *FOR 6.2% WEIGHT LOSS WITH LIFESTYLE-ONLY SUPPORT SOURCE: Average weight loss achieved by participants who completed 10 months of engagement without the use of Anti-obesity medications (AOM). CVS Health® Analytics, 2025.

      • *FOR 47% LESS CLIENT SPEND ON GLP-1S APPROVED FOR WEIGHT LOSS SOURCE: Represents large early adopter client’s anti-obesity medication (AOM) Rx lowered spend relative to their peer cohort after two years in the program. CVS Health® Analytics, 2025.